drugset / Trial / NCT00132626
Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome
Phase 2
Completed
500 enrolled
Institute for Neurodegenerative Disorders
Molecular NeuroImaging · collabNational Institutes of Health (NIH) · collab
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
This study assesses dopamine transporter density using single photon emission computed tomography (SPECT) brain imaging with an investigational radiopharmaceutical, \[123I\]ß-CIT, in research participants with Parkinson's disease.
Timeline
- Start
- 1992-09
- Primary completion
- —
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [123I]ß CIT | Unknown | — | Other |